Page last updated: 2024-10-26

doxazosin and Cognitive Decline

doxazosin has been researched along with Cognitive Decline in 1 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Self-reported withdrawal symptoms also were negatively associated with time to smoking."2.87A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers. ( McKee, SA; Moore, KE; Oberleitner, LM; Roberts, W; Verplaetse, TL, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roberts, W1
Verplaetse, TL1
Moore, KE1
Oberleitner, LM1
McKee, SA1

Trials

1 trial available for doxazosin and Cognitive Decline

ArticleYear
A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers.
    Human psychopharmacology, 2018, Volume: 33, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Attention; Cognitive Dysfunction; Double-Blind Metho

2018